Skip to main content
Signal8

SALZMAN BARRY M

SEC insider (Form 3/4/5 filer). CIK 0001432179. Director at Checkpoint Therapeutics, Inc. (CKPT). 3 reported Form 4/5 transactions since Sep 2024; latest on May 30, 2025. Located in WALTHAM, MA.

Companies SALZMAN BARRY M has filed insider reports for

  • Checkpoint Therapeutics, Inc. (CKPT): Director
SALZMAN BARRY M profile photo

SALZMAN BARRY M

CIK: 0001432179

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)1 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Checkpoint Therapeutics, Inc. logo
CKPT

Checkpoint Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Checkpoint Therapeutics, Inc. logo
    CKPT

    Checkpoint Therapeutics, Inc.

    May 30, 2025
    Tender Offer
    Direct
    147K shares-
  • Checkpoint Therapeutics, Inc. logo
    CKPT

    Checkpoint Therapeutics, Inc.

    May 28, 2025
    Award
    Direct
    12.2K shares-
  • Checkpoint Therapeutics, Inc. logo
    CKPT

    Checkpoint Therapeutics, Inc.

    Dec 13, 2024
    Award
    Direct
    17.6K shares-

1-3 of 3